1165PImmune checkpoint inhibitors following targeted therapies in MITF family translocation renal cell carcinomas. (18th September 2017) - Boileve, A.; Carlo, M.; Barthelemy, P.; Oudard, S.; Borchiellini, D.; Voss, M.; George, S.; Chevreau, C.; Landman-Parker, J.; Tabone, M-D.; Chism, D.; Amin, A.; et al.